CCS(SH:600180) Zheng Quan Zhi Xing·2025-08-29 13:11Overview - The company has recognized impairment losses totaling RMB 36,219,612.34 for the first half of 2025, reflecting its asset status and operational results [1][5] Impairment Loss Details - The impairment losses include: - Accounts receivable impairment loss of RMB 3,126,511.52 - Inventory write-down loss of RMB 37,140,124.94 - Research and development expense impairment loss of RMB 2,207,295.00 - Other receivables bad debt loss of RMB 4,976.31 - Notes receivable impairment loss of RMB 6,272.39 [1][5] Impairment Measurement Methodology - The company measures impairment losses based on expected credit losses over the entire duration of the receivables, categorizing them into different groups based on credit risk characteristics [2][4] - For notes receivable, the classification is based on the credit risk of the accepting bank and the aging of the receivables [2][4] - Other receivables are assessed based on whether the credit risk has significantly increased since initial recognition [4] Impact on Financial Position - The impairment provisions are in compliance with the relevant accounting standards and policies, ensuring an objective and fair reflection of the company's financial condition and operational results [5][6] - The company asserts that the impairment provisions will not adversely affect its normal operations or the interests of shareholders [5]